Skip to content

Clinical trials

Atypical Hemolytic Uremic Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atypical Hemolytic Uremic Syndrome Country / region: United States Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20093
20103
20121
20131
20141
20151
20162
20172
20182
20212
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting3
Terminated3
Active, not recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.11
Hoffmann-La Roche2
Omeros Corporation2
Amgen1
Children's Hospital Medical Center, Cincinnati1
Novartis Pharmaceuticals1
Sanford Health1
University of Rochester1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atypical Hemolytic Uremic Syndrome20
Thrombotic Microangiopathies5
Myasthenia Gravis2
Addison Disease1
Alagille Syndrome1
Alstrom Syndrome1
Amnesia, Transient Global1
Anemia, Hemolytic1
Aniridia1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.